![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 35410 |
FusionGeneSummary for SORL1_NEK4 |
![]() |
Fusion gene information | Fusion gene name: SORL1_NEK4 | Fusion gene ID: 35410 | Hgene | Tgene | Gene symbol | SORL1 | NEK4 | Gene ID | 6653 | 6787 |
Gene name | sortilin related receptor 1 | NIMA related kinase 4 | |
Synonyms | C11orf32|LR11|LRP9|SORLA|SorLA-1|gp250 | NRK2|STK2|pp12301 | |
Cytomap | 11q24.1 | 3p21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | sortilin-related receptorLDLR relative with 11 ligand-binding repeatslow-density lipoprotein receptor relative with 11 ligand-binding repeatsmosaic protein LR11sortilin-related receptor, L(DLR class) A repeats containingsorting protein-related recept | serine/threonine-protein kinase Nek4NIMA (never in mitosis gene a)-related kinase 4never in mitosis A-related kinase 4nimA-related protein kinase 4serine/threonine kinase 2serine/threonine protein kinase-2serine/threonine-protein kinase NRK2serine/ | |
Modification date | 20180527 | 20180523 | |
UniProtAcc | Q92673 | P51957 | |
Ensembl transtripts involved in fusion gene | ENST00000260197, ENST00000532451, ENST00000525532, ENST00000532694, ENST00000534286, ENST00000527934, | ENST00000233027, ENST00000535191, ENST00000383721, | |
Fusion gene scores | * DoF score | 13 X 10 X 7=910 | 3 X 3 X 3=27 |
# samples | 14 | 3 | |
** MAII score | log2(14/910*10)=-2.70043971814109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: SORL1 [Title/Abstract] AND NEK4 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SORL1 | GO:0006605 | protein targeting | 16407538 |
Hgene | SORL1 | GO:0006622 | protein targeting to lysosome | 24523320 |
Hgene | SORL1 | GO:0006892 | post-Golgi vesicle-mediated transport | 17855360 |
Hgene | SORL1 | GO:0014910 | regulation of smooth muscle cell migration | 14764453 |
Hgene | SORL1 | GO:0032091 | negative regulation of protein binding | 16407538 |
Hgene | SORL1 | GO:0034067 | protein localization to Golgi apparatus | 17855360 |
Hgene | SORL1 | GO:0045053 | protein retention in Golgi apparatus | 17855360 |
Hgene | SORL1 | GO:0045732 | positive regulation of protein catabolic process | 24523320 |
Hgene | SORL1 | GO:0051604 | protein maturation | 17855360 |
Hgene | SORL1 | GO:1902430 | negative regulation of amyloid-beta formation | 16407538|22621900 |
Hgene | SORL1 | GO:1902960 | negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | 16407538 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | PRAD | TCGA-EJ-8472-01A | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000260197 | ENST00000233027 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000260197 | ENST00000535191 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000260197 | ENST00000383721 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
intron-intron | ENST00000532451 | ENST00000233027 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
intron-intron | ENST00000532451 | ENST00000535191 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
intron-intron | ENST00000532451 | ENST00000383721 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000525532 | ENST00000233027 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000525532 | ENST00000535191 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000525532 | ENST00000383721 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000532694 | ENST00000233027 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000532694 | ENST00000535191 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000532694 | ENST00000383721 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000534286 | ENST00000233027 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000534286 | ENST00000535191 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000534286 | ENST00000383721 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000527934 | ENST00000233027 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000527934 | ENST00000535191 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
5CDS-intron | ENST00000527934 | ENST00000383721 | SORL1 | chr11 | 121483541 | + | NEK4 | chr3 | 52743951 | - |
Top |
FusionProtFeatures for SORL1_NEK4 |
![]() |
Hgene | Tgene |
SORL1 | NEK4 |
Likely to be a multifunctional endocytic receptor, thatmay be implicated in the uptake of lipoproteins and of proteases.Binds LDL, the major cholesterol-carrying lipoprotein of plasma,and transports it into cells by endocytosis. Binds the receptor-associated protein (RAP). Could play a role in cell-cellinteraction. Involved in APP trafficking to and from the Golgiapparatus. It probably acts as a sorting receptor that protectsAPP from trafficking to late endosome and from processing intoamyloid beta, thereby reducing the burden of amyloidogenic peptideformation. Involved in the regulation of smooth muscle cellsmigration, probably through PLAUR binding and decreasedinternalization. {ECO:0000269|PubMed:14764453,ECO:0000269|PubMed:16174740}. | Protein kinase that seems to act exclusively uponthreonine residues (By similarity). Required for normal entry intoproliferative arrest after a limited number of cell divisions,also called replicative senescence. Required for normal cell cyclearrest in response to double-stranded DNA damage.{ECO:0000250|UniProtKB:Q9Z1J2, ECO:0000269|PubMed:22851694}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SORL1_NEK4 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SORL1_NEK4 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
SORL1 | LRPAP1, GGA1, GGA2, PPP1CA, CUL1, COPS5, COPS6, FBXO6, CFTR, DYRK3, POP1, AURKA, APP, PACS1, FAM76B, HLA-DPA1, RSPO1, LGALS8, FGL1, LGALS9, DLD, FOSL2, WISP3, SP6, ZFP41, FOXI2, ZNF354C, TYW3, ZNF563, ZNF224, ZNF408, ZNF331, EGFL6, ZNF169, FAM19A3, OS9, ZBBX, ZNF517, ZNF264, PSG1, SREBF1, MDK, SCGB1D1, ZNF816, FAM19A4, SOST, CDHR5, ZNF549, GCNT3, CEP97 | NEK4 | ANKRD28, C4BPB, CTDSP2, SPACA1, NRG1, DNAJB2, PLAUR, TXNDC15, HLA-B, HLA-C, SDF4, HLA-E, SKAP1, CBWD1, CBWD2, ISLR, RPGRIP1L, RPGRIP1, XPO1, C1orf85, CD79A, PCDHA12, PRKAB1, LAMP3, SLC18A1, PCDHB11, PCDHGB1, TUBA3C, TUBB1, SLC25A4, HSP90AB2P, CTNNA1, HSP90AB3P, BLM, NPHP4, RPGR |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SORL1_NEK4 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SORL1_NEK4 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SORL1 | C0008370 | Cholestasis | 1 | CTD_human |
Hgene | SORL1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | SORL1 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | NEK4 | C0005586 | Bipolar Disorder | 2 | PSYGENET |